|
Issue |
Title |
|
Vol 22, No 1 (2021) |
A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel |
Abstract
HTML
PDF
|
Cristian Scatena, Roberto Ravasio, Paola Raimondo, Mario Giuliano |
|
Vol 13, No 1 (2012) |
A changing journal in a changing health care |
Details
HTML
PDF
|
Mario Eandi |
|
Vol 18, No 1 (2017) |
A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero |
|
Vol 14, No 4 (2013) |
A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations |
Abstract
HTML
PDF
|
Marco Bellone, Pierluigi Sbarra |
|
Vol 18, No 1 (2017) |
A general model for the estimation of societal costs of lost production and informal care in Italy |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Gianni Ghetti |
|
Vol 15, No 3 (2014) |
A new decision model for economic evaluation of novel therapies for HCV |
Abstract
HTML
PDF
|
Matteo Ruggeri, Americo Cicchetti, Silvia Coretti, Carlo Cammà, Nicola Caporaso, Antonio Gasbarrini |
|
Vol 14, No 1 (2013) |
A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy |
Abstract
HTML
PDF
|
Renzo Colombo, Federico Pellucchi, Lorenzo Rocchini, Carmen Maccagnano, Pablo Katz, Valeria Pegoraro |
|
Vol 13, No 2S (2012) |
Abruzzo |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Abruzzo |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 13, No 1 (2012) |
Access to pharmaceutical products in six European countries – analysis of different pharmaceutical distribution systems |
Abstract
HTML
PDF
|
Evelyn Walter, Aline Dragosits, Monira Said |
|
Vol 18, No 1 (2017) |
Acknowledgement to reviewers (January - December 2017) |
Details
PDF
|
Ombretta Bandi |
|
Vol 19, No 1 (2018) |
Acknowledgement to Reviewers (January - December 2018) |
Details
HTML
PDF
|
Ombretta Bandi |
|
Vol 6, No 4 (2005) |
Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico |
Abstract
PDF
|
Lorenzo Pradelli, Mario Eandi |
|
Vol 12, No 2S (2011) |
Aderenza e persistenza: due elementi chiave per la determinazione dell’efficacia terapeutica in usual care |
Details
PDF
|
Giampiero Mazzaglia, Ovidio Brignoli, Achille P. Caputi, Claudio Cricelli |
|
Vol 13, No 1 (2012) |
Adherence to therapeutic guidelines among patients treated with statins. Results from STAR study |
Abstract
HTML
PDF
|
Luca Degli Esposti, Diego Sangiorgi, Gabriele Lazzeri, Stefano Buda |
|
Vol 12, No 2 (2011) |
Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population |
Abstract
HTML
PDF
|
Luca Degli Esposti, Diego Sangiorgi, Giuseppe Di Pasquale, Gian Franco Gensini, Ido Iori, Stefano Buda, Ezio Degli Esposti |
|
Vol 19, No 1 (2018) |
Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Sara Villa, Giancarlo Castaman |
|
Vol 3, No 1 (2002) |
ALPRAZOLAM: profilo farmacoeconomico nei disturbi d’ansia e da attacchi di panico |
Abstract
PDF
|
Mario Eandi |
|
Vol 20, No 1S (2019) |
An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West |
Abstract
HTML
PDF
|
Giancarlo Casolo, Giuseppe Cavirani, Alessandro Del Carlo, Sergio Iannazzo, Massimo Pardini, Alessandro Squillace |
|
Vol 1, No 2 (2000) |
Analisi comparativa del mercato dei dispositivi per incontinenza in cinque paesi europei |
Abstract
PDF
|
Dante Cornago, Livio Garattini |
|
Vol 6, No 4 (2005) |
Analisi costi-efficacia di 90Y-ibritumomab tiuxetano (Zevalin®) vs. terapie attualmente disponibili nel trattamento dei pazienti affetti da Linfoma Non-Hodgkin (LNH) refrattario o recidivato |
Abstract
PDF
|
Carlo Lazzaro, Manolo Beelke |
|
Vol 5, No 2 (2004) |
Analisi Costo Minimizzazione delle preparazioni di Interferon Beta per il trattamento della Sclerosi Multipla |
Abstract
PDF
|
Francesco Macchia, Pierluigi Russo, Luciano Caprino |
|
Vol 3, No 2 (2002) |
Analisi costo/efficacia della doxofillina vs. teofillina nella terapia dell’asma cronica reversibile dell’adulto |
Abstract
PDF
|
Mario Eandi, Elisa Berno, Lorenzo Pradelli |
|
Vol 5, No 4 (2004) |
Analisi costo/efficacia di sevelamer nel trattamento dell’iperfosforemia del paziente in dialisi |
Abstract
PDF
|
Mario Eandi, Nicola Giotta, Gaia Santagostino Barbone |
|
Vol 6, No 4 (2005) |
Analisi Costo-Efficacia di Amfotericina B Liposomiale (L-AmB) versus Amfotericina B Complesso Lipidico (ABLC) nel trattamento empirico della neutropenia febbrile |
Abstract
PDF
|
Mario Eandi |
|
Vol 4, No 4 (2003) |
Analisi dei costi di buprenorfina vs metadone nella terapia dei soggetti con dipendenza da oppiacei |
Abstract
PDF
|
Giorgio L. Colombo, Guido Faillace, Michele Ferdico |
|
Vol 3, No 3 (2002) |
Analisi della persistenza e delle risorse allocate nel trattamento farmacologico dell’ipertensione arteriosa |
Abstract
PDF
|
Luca Degli Esposti, Alessandro Capone, Ezio Degli Esposti, Giorgio Valpiani, Mirko Di Martino, Gianluca Baio, Pierluigi Russo, Stefano Buda, Alessandra Sturani, Luciano Caprino |
|
Vol 6, No 2 (2005) |
Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule |
Abstract
PDF
|
Roberto Ravasio |
|
Vol 6, No 4 (2005) |
Analisi di costo efficacia nella terapia della BPCO |
Abstract
PDF
|
Sergio Iannazzo, Lorenzo Pradelli, Roberto W. Dal Negro, Mario Eandi |
|
Vol 5, No 4 (2004) |
Analisi di minimizzazione dei costi del trattamento della leucemia cronica con fludarabina fosfato (Fludara®) e.v. e p.o.: metodologia e risultati di un’indagine empirica |
Abstract
PDF
|
Carlo Lazzaro |
|
Vol 6, No 2 (2005) |
Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale |
Abstract
PDF
|
Felice Vadruccio, Giovanni Biricolti, Leonardo Mendolicchio |
|
Vol 21, No 1 (2020) |
Analysis of Market Access Agreements in Turkey |
Abstract
HTML
PDF
|
Guvenc Kockaya, Okan Atalay, Mustafa Kurnaz, Selin Okcun, Nazlı Sencan, Cigdem Gedik, Mete Saylan, Gulpembe Oguzhan |
|
Vol 17, No 1 (2016) |
Analysis of the treatment cost of HIV/AIDS in Turkey |
Abstract
HTML
PDF
|
Guvenc Kockaya, Tuba Elbir Zengin, Fatma Betul Yenilmez, Canan Dalgic, Simten Malhan Simten Malhan, Pamir Cerci, Ergun Oksuz, Serhat Unal |
|
Vol 11, No 2 (2010) |
Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept |
Abstract
PDF
|
Viola Sacchi, Orietta Zaniolo, Ignazio Olivieri |
|
Vol 9, No 1S (2008) |
Appendice |
Details
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 3, No 2 (2002) |
Appropriatezza clinica ed economica: strumenti e modelli di valutazione e gestione dell’attività psichiatrica |
Abstract
PDF
|
Carmine Munizza, Salvatore Nieddu, Maurizio Bianco |
|
Vol 23, No 1 (2022) |
Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis |
Abstract
HTML
PDF
|
Francesco Mennini, Daniele Rossi, Andrea Marcellusi |
|
Vol 13, No 3 (2012) |
Assessment of the innovative quality of agomelatine through the Innovation Assessment Algorithm |
Abstract
HTML
PDF
|
Liliana Civalleri, Sabrina Licata |
|
Vol 8, No 2 (2007) |
Asthma and public awareness in Italy: results from CHAOS (Chronic Airway Obstruction Survey) |
Abstract
PDF
|
Stefano Uleri, Roberto W. Dal Negro |
|
Vol 8, No 1S (2007) |
Atti del I Convegno. Laboratorio dose unitaria Galenica clinica e gestione del rischio: modelli ed esperienze |
Details
PDF
|
Alessandro D’Arpino, Francesca Venturini, Luigi Giuliani, Ilario Viano, Oscar Alabiso, Massimo Boni, Maria Rachele Chiappetta, Stefano Federici, Franca Goffredo, Antonella Cannas, Paolo Serra |
|
Vol 2, No 4 (2001) |
Automedicazione: una risorsa economica da valorizzare |
Abstract
|
Carlo Lucioni, Luca Zappaterra |
|
Vol 13, No 2S (2012) |
Basilicata |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Basilicata |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 8, No 1 (2007) |
Bayesian statistic methods and theri application in probabilistic simulation models |
Abstract
PDF
|
Sergio Iannazzo |
|
Vol 7, No 1 (2006) |
Bayesian statistic methods and theri application in probabilistic simulation models |
Abstract
PDF
|
Orietta Zaniolo, Mario Eandi |
|
Vol 13, No 2S (2012) |
Bolzano |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Bolzano |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 17, No 3 (2016) |
Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy |
Abstract
HTML
PDF
|
Marco Bellone, Roberto Di Virgilio, Paolo Di Rienzo |
|
Vol 15, No 1S (2014) |
Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro |
|
Vol 18, No 1 (2017) |
Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation |
Abstract
HTML
PDF
|
Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio |
|
Vol 18, No 1 (2017) |
Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients |
Abstract
HTML
PDF
|
Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio |
|
Vol 17, No 1 (2016) |
Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients |
Abstract
HTML
PDF
|
Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce |
|
Vol 10, No 1 (2009) |
Budget impact analysis of the use of lapatinib in the treatment of breast cancer in Italy |
Abstract
PDF
|
Francesco Bamfi, Federica Basso, Massimo Aglietta, Carmelo Bengala, Vito Lorusso, Paolo Pronzato, Maria Caterina Cavallo, Orietta Zaniolo, Sergio Iannazzo |
|
Vol 15, No 3 (2014) |
Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease |
Abstract
HTML
PDF
|
Valentina Lorenzoni, Giuseppe Turchetti |
|
Vol 10, No 1 (2009) |
Budget impact analysis of the use of rituximab in the treatment of rheumatoid arthritis in Italy |
Abstract
PDF
|
Maurizio Benucci, Sergio Iannazzo, Luciano Sabadini |
|
Vol 10, No 1 (2009) |
Budget impact analysis of use of aliskiren in hypertension on the Italian Health Care System |
Abstract
PDF
|
Orietta Zaniolo, Lorenzo Pradelli |
|
Vol 13, No 3 (2012) |
Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy |
Abstract
HTML
PDF
|
Francesco Mennini, Sergio Russo, Andrea Marcellusi |
|
Vol 8, No 1 (2007) |
Budget impact of rosiglitazone in type 2 diabetes |
Abstract
PDF
|
Orietta Zaniolo, Francesco Bamfi, Sergio Iannazzo |
|
Vol 9, No 3 (2008) |
Budget impact of vildagliptin |
Abstract
PDF
|
Orietta Zaniolo, Viola Sacchi, Lorenzo Pradelli |
|
Vol 23, No 1 (2022) |
Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy |
Abstract
HTML
PDF
|
Patrizia Berto, Marco Bellone, Alice Sabinot, Carmine Pinto, Massimo Martino, Daniele Generali, Pier Luigi Carriero, Maria Domenica Sanna |
|
Vol 13, No 2S (2012) |
Calabria |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Calabria |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 13, No 2S (2012) |
Campania |
Abstract
HTML
PDF
|
Roberto Gasparini, Donatella Panatto, Bruna Dirodi, Rosa Prato, Gianni Amunni, Valter Turello, Luigi Sudano, Paolo Cristoforoni, Sara Boccalini, Paolo Bonanni |
|
Vol 9, No 1S (2008) |
Campania |
Abstract
PDF
|
Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi |
|
Vol 14, No 1 (2013) |
Can market structure explain cross-country differences in health? |
Abstract
HTML
PDF
|
Kate Rybczynski, Lori Curtis |
|
Vol 13, No 1S (2012) |
Cetuximab in first line treatment of metastatic colorectal cancer |
Abstract
HTML
PDF
|
Carlo Barone, Andrea Belisari, Fortunato Ciardiello, Lorenzo Mantovani, Lucia D’Angiolella, Gianluca Furneri, Nicola Normanno, Patrizio Piacentini, Carmine Pinto |
|
Vol 13, No 1 (2012) |
Clinical and economic impact of aliskiren in uncontrolled hypertensive patients |
Abstract
HTML
PDF
|
Ezio Degli Esposti, Radovan Tomic |
|
Vol 12, No 2 (2011) |
Clinical and economic profile of entecavir in the treatment of chronic hepatitis b virus infection |
Abstract
HTML
PDF
|
Mario Eandi |
|
Vol 13, No 3 (2012) |
Clinical and economic profile of prucalopride in the treatment of chronic constipation in women |
Abstract
HTML
PDF
|
Vincenzo Stanghellini, Mario Eandi |
|
Vol 21, No 1S (2020) |
Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes |
Abstract
HTML
PDF
|
Edoardo Mannucci, Pier Paolo Mangia, Lorenzo Pradelli |
|
Vol 7, No 3 (2006) |
Clinical and pharmacoeconomic profile of esomeprazole in acid-related diseases |
Abstract
PDF
|
Orietta Zaniolo |
|
Vol 11, No 1 (2010) |
Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients |
Abstract
PDF
|
Mario Eandi |
|
Vol 21, No 1 (2020) |
Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer |
Abstract
HTML
PDF
|
Giovanni Gancitano, Roberto Ravasio, Lorenzo Cattelino, Paolo Di Procolo, Diego Cortinovis |
|
Vol 4, No 2 (2003) |
Commenti al lavoro di Colombo GL, Muzio A “Gli inibitori di pompa protonica nelle patologie acido-correlate: il ruolo di rabeprazolo in una strategia di cost minimisation” |
Details
PDF
|
Cristina Rossi, Giancarlo Benelli |
|
Vol 6, No 3 (2005) |
Commenti all’articolo: “Interruzione del trattamento nei pazienti con schizofrenia che ricevono olanzapina o aripiprazolo: metanalisi degli studi clinici controllati” |
Details
PDF
|
Giovanni Battista Leproux, Michele Intorcia |
|
Vol 15, No 1S (2014) |
Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients |
Abstract
HTML
PDF
|
Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro |
|
Vol 16, No 3 (2015) |
Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US |
Abstract
HTML
PDF
|
Massimiliano Povero, Lorenzo Pradelli |
|
Vol 16, No 1S (2015) |
Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis |
Abstract
HTML
PDF
|
Massimiliano Povero, Lorenzo Pradelli |
|
Vol 4, No 3 (2003) |
Considerazioni cliniche ed economiche nel trattamento del cancro della prostata: analisi costo-efficacia di bicalutamide vs flutamide in combinazione con LHRH |
Abstract
PDF
|
Monia Marchetti, Giorgio Lorenzo Colombo |
|
Vol 13, No 2 (2012) |
Consumer preferences for the predictive genetic tests for Alzheimer’s disease |
Abstract
HTML
PDF
|
Ming-Yi Huang, Matthew Perri III |
|
Vol 21, No 1 (2020) |
Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/1 |
Abstract
HTML
PDF
|
[No authors listed] |
|
Vol 21, No 1 (2020) |
Corrigendum: An Integrated Management Model of Patients With Atrial Fibrillation: The Experience of the Local Health Unit Tuscany North-West/2 |
Abstract
HTML
PDF
|
[No authors listed] |
|
Vol 20, No 1 (2019) |
Corrigendum: Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs |
Abstract
HTML
PDF
|
[No authors listed] |
|
Vol 16, No 2 (2015) |
Cost analysis of inappropriate treatments for suspected dermatomycoses |
Abstract
HTML
PDF
|
Emanuela Fiammenghi, Angela Patalano, Viviana Lo Conte, Gabriella Calabrò |
|
Vol 16, No 1 (2015) |
Cost differentials of dental outpatient care across clinical dentistry branches |
Abstract
HTML
PDF
|
Jovana Rančić, Nemanja Rančić, Nemanja Majstorović, Vladimir Biočanin, Marko Milosavljević, Mihajlo Jakovljević |
|
Vol 20, No 1 (2019) |
Cost Minimization Analysis of Radiofrequency Compared to Laser Thermal Ablation in Patients with Hepatocellular Carcinoma |
Abstract
HTML
PDF
|
Maria Guarino, Lucia Sara D'Angiolella, Luigia Falco, Federica Morando, Giovan Giuseppe Di Costanzo, Filomena Morisco, Giovanni Improta, Lorenzo Giovanni Mantovani, Nicola Caporaso |
|
Vol 17, No 2 (2016) |
Cost of care of chronic non-communicable diseases in Jamaican patients: the role of obesity |
Abstract
HTML
PDF
|
Christine M. Fray-Aiken, Rainford J. Wilks, Abdullahi O. Abdulkadri, Affette M. McCaw-Binns |
|
Vol 16, No 3 (2015) |
Cost of illness of advanced ovarian carcinoma in Italy: results of an empirical, single-centre study |
Abstract
HTML
PDF
|
Carlo Lazzaro, Francesco Plotti, Stella Capriglione, Matteo Ferrario, Roberto Angioli |
|
Vol 13, No 3 (2012) |
Cost of illness of community-acquired pneumonia. Review of the literature and possible strategies in the Serbian health care setting |
Abstract
HTML
PDF
|
Mihajlo Jakovljevic, Vojislav Cupurdija, Zorica Lazic |
|
Vol 12, No 3 (2011) |
Cost of osteoporosis-related fracture in Italy. Results of the BLOCK study |
Abstract
HTML
PDF
|
Luca Degli Esposti, Silvano Adami, Giovanni Iolascon, Alfredo Nardi, Luca Pietrogrande, Giuseppina Resmini, Maurizio Rossini, Umberto Tarantino, Paolo Tranquilli Leali, Carlo Trevisan, Alessandra Cheli, Chiara Veronesi, Stefano Buda |
|
Vol 11, No 2 (2010) |
Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes |
Abstract
PDF
|
Simona Cammarota, Enrica Menditto, Daria Putignano, Anna Citarella |
|
Vol 11, No 2 (2010) |
Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy |
Abstract
PDF
|
Orietta Zaniolo, Sorrel E. Wolowacz, Lorenzo Pradelli |
|
Vol 19, No 1 (2018) |
Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer |
Abstract
HTML
PDF
|
Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis |
|
Vol 22, No 1 (2021) |
Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy |
Abstract
HTML
PDF
|
Massimiliano Povero, Lorenzo Pradelli, Andrea Serra, Francesca Fanelli, Luca Gazzi |
|
Vol 20, No 1 (2019) |
Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective |
Abstract
HTML
PDF
|
Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini |
|
Vol 18, No 1 (2017) |
Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study |
Abstract
HTML
PDF
|
Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni |
|
Vol 7, No 2 (2006) |
Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer |
Abstract
PDF
|
Mario Eandi |
|
Vol 19, No 1 (2018) |
Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis |
Details
HTML
PDF
|
Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico |
|
Vol 12, No 2 (2011) |
Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice |
Abstract
HTML
PDF
|
Orietta Zaniolo, Sergio Iannazzo, Gian Piero Patrucco, Roberto Bellini |
|
Vol 23, No 1 (2022) |
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy |
Abstract
HTML
PDF
|
Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Alessandra Cardillo, Laura Santoni, Luca Prosperini |
|
1 - 100 of 480 Items |
1 2 3 4 5 > >> |